Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Covetrus, Inc.    CVET

COVETRUS, INC.

(CVET)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.
Strengths
  • As regards fundamentals, the enterprise value to sales ratio is at 0.96 for the current period. Therefore, the company is undervalued.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • For the past twelve months, EPS forecast has been revised upwards.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The stock is in a well-established, long-term rising trend above the technical support level at 13 USD
Weaknesses
  • The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
  • Technically, the stock approaches a strong medium-term resistance at USD 28.29.
  • Low profitability weakens the company.
Sector Medical Equipment, Supplies & Distribution - NEC
1st jan.Capitalisation (M$)Investor Rating
COVETRUS, INC.104.66%3 445
ABBOTT LABORATORIES24.59%191 805
MEDTRONIC PLC0.22%152 480
BECTON, DICKINSON AND COMPA..-13.65%68 111
HOYA CORPORATION33.11%49 894
BAXTER INTERNATIONAL INC.-9.03%38 858
ALIGN TECHNOLOGY, INC.72.48%37 950
SARTORIUS STEDIM BIOTECH105.15%33 382
ZIMMER BIOMET HOLDINGS-0.37%30 909
DEXCOM, INC.46.15%30 698
TERUMO CORPORATION6.74%30 026
SYSMEX CORPORATION46.73%21 881
AMERISOURCEBERGEN CORPORATI..21.38%21 060
WEST PHARMACEUTICAL SERVICE..84.90%20 342
STERIS PLC27.16%16 537
BIO-RAD LABORATORIES, INC.45.53%16 074
More Results
Financials (USD)
Sales 2020 4 272 M - -
Net income 2020 -23,0 M - -
Net Debt 2020 675 M - -
P/E ratio 2020 -113x
Yield 2020 -
Capitalization 3 445 M 3 445 M -
EV / Sales 2020 0,96x
EV / Sales 2021 0,89x
Nbr of Employees 5 300
Free-Float 72,5%
Upcoming event on COVETRUS, INC.
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio -
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes